To further validate whether PCNA could reverse the inhibitory effects of EIF3B knockdown on cholangiocarcinoma, we conducted separate transfections of a PCNA overexpression plasmid and an EIF3B knockdown plasmid, as well as simultaneous transfections, in REB cells. This evidence concerns the gene EIF3B and cholangiocarcinoma.